Validated Insights Issues Report Update: Trade School Enrollments to Continue Strong Growth, Driven by Gen Z
Newest quarterly report from Validated Insights predicts enrollments in trade schools and trade programs will increase 6% annually. CHICAGO–(BUSINESS WIRE)–#ed–According... Read more.
Nuvation Bio Receives Approval from Japan’s Ministry of Health, Labour and Welfare for IBTROZITM for Patients with Advanced ROS1-positive Non-Small Cell Lung Cancer
IBTROZI will be marketed in Japan by Nippon Kayaku Approval is based on the pivotal Phase 2 TRUST studies, demonstrating IBTROZI’s high rates and durability... Read more.
Generative AI Models Market Report 2025-2035: Multimodal Content Creation Fuels Growth Through 2035 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Generative AI Models Market Report 2025-2035” has been added to ResearchAndMarkets.com’s offering. World... Read more.
India Banking as a Service (BaaS) Market Dynamics Report 2025-2030 | Businesses Embrace BaaS to Cut Costs, Expand Financial Offerings, and Deliver Enhanced Customer Experiences – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Banking as a Service (BaaS) Market in India (2025 – 2030)” report has been added to ResearchAndMarkets.com’s... Read more.
Mark R. DeFazio Honored at Grand Opening of Boro Park JCC Community Center
Metropolitan Commercial Bank’s CEO Front and Center Celebrating Expansion and Community Impact NEW YORK–(BUSINESS WIRE)–#mcb–Mark R. DeFazio,... Read more.
Dentalcorp Declares Dividend and Announces Release Date for Third Quarter 2025 Results
TORONTO–(BUSINESS WIRE)–dentalcorp Holdings Ltd. (“Dentalcorp” or the “Company”) (TSX: DNTL), Canada’s largest and one of North America’s... Read more.
KalVista Pharmaceuticals Announces European Commission and Swissmedic Approval of EKTERLY® (sebetralstat), First and Only Oral On-Demand Treatment for Hereditary Angioedema
First European launch of EKTERLY expected in Germany Q4 2025 EKTERLY now approved in the US, EU, UK and Switzerland with additional regulatory applications under... Read more.
New MindMed Retrospective Study Presented at Psych Congress 2025 Reveals High Rates of Suicidal Ideation (SI) in Adults with Generalized Anxiety Disorder (GAD)
Nearly 50% of individuals with severe GAD reported experiencing SI almost daily Findings highlight the link between anxiety severity and SI, underscoring the need... Read more.
United Therapeutics Corporation to Review Data from the Successful TETON-2 Pivotal Study of Nebulized Tyvaso® in Idiopathic Pulmonary Fibrosis
SILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C.–(BUSINESS WIRE)–United Therapeutics Corporation (Nasdaq: UTHR) announced today that it will host... Read more.
TRYNGOLZA® (olezarsen) approved in the European Union for familial chylomicronemia syndrome (FCS)
CARLSBAD, Calif.–(BUSINESS WIRE)–Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) and Sobi® today announced that TRYNGOLZA® (olezarsen) has been approved... Read more.